NMTC vs ROP · rev $3.5M vs P/E 41, rev $1.88B
Neuroone Medical Technologies Corp (NMTC) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported NMTC revenue for 2024-09-30 was $3.5M. Net income was -$12.3M. Revenue was up 76.9% from 2023-09-30 to 2024-09-30. NMTC currently screens at market cap $35.5M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
NMTC currently screens at market cap $35.5M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the NMTC and ROP stock pages for the full models.
Not investment advice.